Reinhard joined the European Vaccine Initiative in 2022. He has a research background in epigenetics with a special focus on RNA modifications and holds a PhD in Molecular Biology from Heidelberg University and German Cancer Research Center (DKFZ). Prior to joining EVI, Reinhard worked as Scientific Coordinator at the National Center for Tumor Diseases (NCT) Heidelberg. With a history of working in research and the hospital & health care sector, he is experienced in management of scientific as well as clinical and administrative projects. Reinhard is passionate about contributing to the clinical and societal impact of EVI.